BSECompany Update6d ago · 14 Aug 2026, 05:30 pm
Disclosure under Regulation 30 of Listing Regulations regarding incorporation of Wholly owned subsidiary in Singapore.
Ganesh Benzoplast Ltd · 500153
✦ AI SummaryExpansion
Ganesh Benzoplast Ltd has incorporated a Wholly Owned Subsidiary in Singapore, GANESH BENZOPLAST (SINGAPORE) PTE. LTD., with an initial capital of S$ 1,34,260.
Analysis Scores
Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk3/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Ganesh Benzoplast Ltd - 500153 - Disclosure Under Regulation 30-Incoporation Of Wholly Owned Subsidiary
Attachments (1)
📄pdf
Download →
6a7a7297-470c-4db3-a324-1015c433d910.pdf
View document text
GANESH BENZOPLAST LIMITED
CIN: L24200MH1986PLC039836
Regd. Office: Dina Building, 1st Floor, 53, Maharshi Karve Road, Marine Lines, Mumbai - 400 002
Tel: 022- 6140 6000/22001928
Email: compliance@gblinfra.com Website: www.ganeshbenzoplast.com
August 14, 2026
The General Manager, The Manager,
Department of Corporate Services – Corporate Listing Department
Relations Department, National Stock Exchange of India Limited
BSE Limited, Exchange Plaza, 5th Floor,
Pheeroze Jeejeebhoy Towers, Plot No. C/1, G-Block, Bandra Kurla
Dalal Street, Fort, Complex,
Mumbai – 400 001. Bandra (E), Mumbai – 400051
Scrip ID: 500153 Scrip ID: GANESHBE
Dear Sir/Madam,
Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulation, 2015 (“SEBI Listing Regulations”) – Intimation for Incorporation of
Wholly Owned Subsidiary
Further to our intimation dated May 27, 2026, regarding the approval accorded by the Board of Directors for
the incorporation of a Wholly Owned Subsidiary (“WOS”) in Singapore, and pursuant to Regulation 30 read
with Para A of Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and
Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), we hereby inform you that the Company
has incorporated its Wholly Owned Subsidiary on August 13, 2026 in Singapore under the name GANESH
BENZOPLAST (SINGAPORE) PTE. LTD.
The relevant details pursuant to Regulation 30 of the SEBI Listing Regulations read with SEBI Circular
SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, are enclosed as Annexure-A.
You are requested to take note of the above on record and disseminated to all concerned.
Thanking You,
Yous Faithfully,
For Ganesh Benzoplast Limited
Rishi Pilani
Chairman & Managing Director
(DIN 00901627)
Corp Office: 501/ 502, 'C' Wing, Lotus Corporate Park, Off. Western Express Highway, Laxmi
Nagar, Goregaon (East), Mumbai - 400063.
GANESH BENZOPLAST LIMITED
CIN: L24200MH1986PLC039836
Regd. Office: Dina Building, 1st Floor, 53, Maharshi Karve Road, Marine Lines, Mumbai - 400 002
Tel: 022- 6140 6000/22001928
Email: compliance@gblinfra.com Website: www.ganeshbenzoplast.com
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated
November 11, 2024
S. No. Particulars Details
1 Name of the target entity, details in brief such as size, GANESH BENZOPLAST
turnover etc. (SINGAPORE) PTE. LTD. has been
incorporated on August 13, 2026.
Country of Incorporation: Singapore
Share capital: S$ 1,34,260
Size/Turnover: Not Applicable since the
Company (yet to commence business
operations)
2 Whether the acquisition would fall within related Not applicable, as the Company is a
party transaction(s) and whether the promoter/ Wholly Owned Subsidiary (WOS)
promoter group/ group companies have any interest
in the entity being acquired? If yes, nature of interest
and details thereof and whether the same is done at
“arms length”
3 Industry to which the entity being acquired belongs Trading of chemicals and chemical
products & General Warehousing
4 Objects and impact of acquisition (including but not Not applicable, as this is incorporation of a
limited to, disclosure of reasons for acquisition of wholly owned subsidiary. WOS formed for
target entity, if its business is outside the main line of the purpose of expanding & growing the
business of the listed entity business of the Company and the WOS
shall be engaged in activities aligned with
the Company’s strategic business plans, in
accordance with the applicable laws of
India and Singapore.
5 Brief details of any governmental or regulatory Not applicable
approvals required for the acquisition
6 Indicative time period for completion of the Not applicable
acquisition;
7 Consideration whether cash consideration or share The initial capital of the Wholly Owned
swap or any other form and details of the same; Subsidiary will be in the form of cash.
8 Cost of acquisition and/or the price at which the Not applicable
shares are acquired
9 Percentage of shareholding / control acquired and / 100%
or number of shares acquired
Corp Office: 501/ 502, 'C' Wing, Lotus Corporate Park, Off. Western Express Highway, Laxmi
Nagar, Goregaon (East), Mumbai - 400063.
GANESH BENZOPLAST LIMITED
CIN: L24200MH1986PLC039836
Regd. Office: Dina Building, 1st Floor, 53, Maharshi Karve Road, Marine Lines, Mumbai - 400 002
Tel: 022- 6140 6000/22001928
Email: compliance@gblinfra.com Website: www.ganeshbenzoplast.com
10 Brief background about the entity acquired in terms Date of incorporation is August 13, 2026
of products/line of business acquired, date of as per the Certificate of Incorporation
incorporation, history of last 3 years turnover, issued on August 13, 2026.
country in which the acquired entity has presence and
any other significant information (in brief) WOS is yet to commence its business
operations.
Corp Office: 501/ 502, 'C' Wing, Lotus Corporate Park, Off. Western Express Highway, Laxmi
Nagar, Goregaon (East), Mumbai - 400063.